Associations of bolus insulin injection frequency and smart pen engagement with glycaemic control in people living with type 1 diabetes
Diabetes, Obesity and Metabolism · 2024
DOI: 10.1111/dom.15316 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2024. Verfasst von Jarl Hellman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences, Uppsala University, Uppsala, Sweden. Hauptthemen laut MEDLINE: Insulin, Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Novo Nordisk A/S.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aim
To evaluate whether both bolus insulin injection frequency and smart pen engagement were associated with changes in glycaemic control, using real‐world data from adults with type 1 diabetes (T1D). Materials and Methods Adults using a smart pen (NovoPen 6) to administer bolus insulin (fast‐acting insulin aspart or insulin aspart) alongside continuous glucose monitoring were eligible for inclusion. Smart pen engagement was characterized by number of days with pen data uploads over the previous 14 days. Glycaemic control was evaluated by analysing glucose metrics.
Results
Overall, data from 1194 individuals were analysed. The number of daily bolus injections was significantly associated with time in range (TIR; 3.9‐10.0 mmol/L [70‐180 mg/dL]; P < 0.0001). Individuals administering, on average, three daily bolus insulin injections had an estimated 11% chance of achieving >70% TIR. The probability of achieving >70% TIR increased with the mean number of daily bolus injections. However, the percentage of TIR was lower on days when individuals administered higher‐than‐average numbers of injections. The observed mean number of daily bolus injections administered across the study population was lower than the optimal number required to reach glycaemic targets (4.8 injections vs. 6‐8 injections). Smart pen engagement was significantly associated with improved TIR.
Conclusions
Glycaemic control was associated with daily bolus insulin injection frequency and smart pen engagement. A treatment regimen combining an optimal bolus injection strategy, and effective smart pen engagement, may improve glycaemic control among adults with T1D.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
- Novo Nordisk A/S, Søborg, Denmark.
- School of Medical Science, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
ORCID-Profile: Jarl Hellman, Niels Vaever Hartvig, Mads Reinholdt Sørensen, Johan Jendle
Förderung
- Novo Nordisk A/S
Zitieren
APA
Hellman, J., Hartvig, N. V., Kaas, A., Møller, J. B., Sørensen, M. R., & Jendle, J. (2024). Associations of bolus insulin injection frequency and smart pen engagement with glycaemic control in people living with type 1 diabetes. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.15316
Vancouver
Hellman J, Hartvig NV, Kaas A, Møller JB, Sørensen MR, Jendle J. Associations of bolus insulin injection frequency and smart pen engagement with glycaemic control in people living with type 1 diabetes. Diabetes, Obesity and Metabolism. 2024. doi:10.1111/dom.15316
BibTeX
@article{Hellman2024,
author = {Hellman, Jarl and Hartvig, Niels Vaever and Kaas, Anne and Møller, Jonas Bech and Sørensen, Mads Reinholdt and Jendle, Johan},
title = {Associations of bolus insulin injection frequency and smart pen engagement with glycaemic control in people living with type 1 diabetes},
journal = {Diabetes, Obesity and Metabolism},
year = {2024},
doi = {10.1111/dom.15316}
}
EUVIMED